Pharma channel feed

No­var­tis ac­cus­es 2 AveX­is founders of al­ter­ing da­ta, stonewalling probe — but ex-CSO blasts back

6 years ago
Cell/Gene Tx
FDA+

Servi­er be­gins manslaugh­ter tri­al over weight loss drug

6 years ago

Here comes the oral GLP-1 drug for di­a­betes — and No­vo Nordisk wants to price Ry­bel­sus 'at a sim­i­lar lev­el as Ozem­pic'

6 years ago
R&D

Astel­las' AML drug wins over CHMP — strength­en­ing lead on Dai­ichi Sankyo

6 years ago

Pur­due threat­ens to walk away from set­tle­ment, asks to pay em­ploy­ees mil­lions in bonus­es

6 years ago

Genen­tech sub­mits a big plan to ex­pand its South San Fran­cis­co foot­print

6 years ago
R&D

Em­maus re­scinds EU mar­ket­ing ap­pli­ca­tion, fol­low­ing neg­a­tive re­view

6 years ago
FDA+

While No­var­tis ban­ish­es Zol­gens­ma scan­dal scars — Bio­gen goes on a Spin­raza 'of­fen­sive'

6 years ago
R&D

Speak­er Nan­cy Pelosi to un­veil bill for fed­er­al­ly ne­go­ti­at­ed drug prices

6 years ago
People

Zol­gens­ma did­n't cause an in­fant death, AveX­is ex­ecs say as they spot­light long-term da­ta

6 years ago
R&D
Cell/Gene Tx

Sen­a­tors to FTC: Don't let the big Cel­gene and Al­ler­gan buy­outs hurt R&D and con­sumers

6 years ago
People
R&D

Af­ter tout­ing Gazy­va's po­ten­tial in lu­pus, Roche nabs 'break­through' ahead of PhI­II

6 years ago

Pop­u­la­tion phar­ma­co­ki­net­ics: Drug­mak­ers seek clar­i­ty and ad­di­tions to re­vised FDA guid­ance

6 years ago
FDA+

Scott Got­tlieb has a new board po­si­tion to add to the re­sume — and this one is fo­cused on a fa­vorite sub­ject

6 years ago
People

Pur­due Phar­ma files for bank­rupt­cy as first step in $10B opi­oid set­tle­ment

6 years ago

Ver­tex deal for Scot­land — no deal for Eng­land

6 years ago
FDA+

Roche's Tecen­triq ex­cels in an­oth­er lung can­cer study

6 years ago
R&D

Look out Alex­ion, Roche breaks out the de­tails on its ri­val rare CNS drug

6 years ago
R&D

In­di­an man­u­fac­tur­ing play­er Ju­bi­lant poach­es top No­var­tis BD ex­ec to run their new biotech start­up in Yard­ley, PA

6 years ago
People

CDER chief Janet Wood­cock has a mes­sage for phar­ma: 'It’s not work­ing, and it won’t work in the fu­ture'

6 years ago
People

Aca­dia de­clares ear­ly win on Nu­plazid de­men­tia study, stun­ning an­a­lysts and send­ing shares soar­ing

6 years ago
R&D

Boehringer In­gel­heim's Ofev wins FDA ap­proval for use in scle­ro­der­ma pa­tients

6 years ago
FDA+

Genen­tech reach­es set­tle­ment with Tai­wanese biotech ac­cused of steal­ing trade se­crets — but will keep su­ing ex-staffers

6 years ago

Roche boosts can­cer ap­provals in Eu­rope, push­ing for a big­ger slice of the I/O pie

6 years ago
R&D
First page Previous page 262263264265266267268 Next page Last page
A service from the Financial Times